Health CanadaGeneral Alert
Importation of USA-authorized Carbamazepine Extended-Release Tablets, USP 200 mg...
Published: June 5, 2024Recall ID: 75612Category: generalCountry: Canada
Reason for Recall / Hazard
Labelling - Supply - Product safety
Product Description & Identification
Importation of USA-authorized Carbamazepine Extended-Release Tablets, USP 200 mg and 400 mg due to the current shortage of Canadian-authorized carbamazepine
Affected Products
Carbamazepine Extended-Release Tablets, USP 200 mg and 400 mg
Additional Source Details
| Field | Value |
|---|---|
| N I D | 75612 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/importation-usa-authorized-carbamazepine-extended-release-tablets-usp-200-mg-and-400 |
| Issue | Labelling - Supply - Product safety |
| Title | Importation of USA-authorized Carbamazepine Extended-Release Tablets, USP 200 mg and 400 mg due to the current shortage of Canadian-authorized carbamazepine |
| Product | Carbamazepine Extended-Release Tablets, USP 200 mg and 400 mg |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2024-06-05 |
| Organization | Marketed health products |